Mathew MacCumber (Rush University Medical Centre, Chicago) provides seom updates from the DCRC Retina Protocls including the findings from Protocol V.
1. What have been the most important developments in DME in the last year?
2. What is the current standard of care for patients with centre-involved DME with good vision?
3. Could you tell us a little about the Protocol V trial and its findings?
4. What have been the most interesting findings from the other DRCR Retina Network Protocols ongoing trials?
Disclaimer: The thoughts and opinions expressed in this video are those of Mathew MacCumber and don’t necessarily reflect though of the DRCR Retina Network.
Support: No funding was received in the production of this video.
Share this Video
Related Videos In Retina/Vitreous
Sunir Garg, Hawaiian Eye 2022: Mask Use and Endophthalmitis
Universal mask use was shown to be effective at reducing incidence of endophthalmitis, according to results of a study presented at Hawaiian Eye 2022. We caught up with Dr Sunir Garg (Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA), who gave us an overview of his retrospective review on mask use and […]
Sunir Garg, Hawaiian Eye 2022: Intravitreal Injections and Endophthalmitis
Universal mask use was shown to be effective at reducing incidence of endophthalmitis, according to results of a study presented at Hawaiian Eye 2022. We had the honour of interviewing Dr Sunir Garg (Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA) about his talk on the causes of endophthalmitis and its relationship […]
J Fernando Arevalo, AAO 2021: Highlights and Future Perspectives
We were honored to have the opportunity to ask J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA) about his highlights from the American Academy of Ophthalmology Virtual Meeting 2021. Speaker Disclosure: J Fernando Arevalo has received consultant and advisor fees from Abbvie, Genentech and Thea Laboratories, patents/royalty from […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!